Clinical Trial Update: Carbohydrate Metabolism Disorder Frequency in Hypertriglyceridemia Induced by Bexarotene of Cutaneous T Cell Lymphoma [Phase 4]

View source ↗

Summary

Phase 4 trial update reporting how often carbohydrate metabolism disorders occur in bexarotene-induced hypertriglyceridemia associated with cutaneous T-cell lym…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous T-cell Lymphoma
• Hypertriglyceridemia

Drugs mentioned

• Bexarotene (Bexarotene)

Snippet

Sponsor: Rennes University Hospital | Conditions: Hypertriglyceridemia, Cutaneous T Cell Lymphoma | Phase 4 | Status: COMPLETED